Inhibition of prostaglandin E2 production by flavone and its related compounds. 2010

Tadayoshi Kaneko, and Hiroshige Chiba, and Norio Horie, and Takao Kato, and Masaki Kobayashi, and Ken Hashimoto, and Kaoru Kusama, and Hiroshi Sakagami
Department of Oral and Maxillofacial Surgery, Tokyo Medical University, Shinjyuku-ku, Tokyo, Japan.

We have previously reported that among 12 major ingredients of Sairei-to, Scutellariae radix inhibited prostaglandin E(2) (PGE(2)) production by lipopolysaccharide (LPS)-activated mouse macrophage-like RAW264.7 cells more efficiently than other ingredients, and wogonin, a major flavonoid from Scutellariae radix, showed greater inhibitory activity and membrane permeability than baicalein and baicalin. Here the effects of six other flavonoids, with similar structures, on membrane permeability and PGE(2) production were investigated. 7-Methoxyflavone inhibited the LPS-stimulated PGE(2) production to the greatest extent, followed by flavone>wogonin (5,7-dihydroxy-8-methoxyflavone)>> 7,8-dimethoxyflavone>chrysin (5,7-dihydroxyflavone)> baicalein (5,6,7-trihydroxyflavone)>>chromone. 7-Methoxyflavone also showed the highest membrane permeability, followed by flavone>chrysin>7,8-dimethoxy-flavone>wogonin>baicalein. When PGE(2) inhibitory activity was expressed per molecule incorporated into the cells, wogonin produced the greatest inhibition, further substantiating its anti-inflammatory potency.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002463 Cell Membrane Permeability A quality of cell membranes which permits the passage of solvents and solutes into and out of cells. Permeability, Cell Membrane
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D015232 Dinoprostone The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa. PGE2,PGE2alpha,Prostaglandin E2,Prostaglandin E2alpha,PGE2 alpha,Prepidil Gel,Prostaglandin E2 alpha,Prostenon,E2 alpha, Prostaglandin,E2, Prostaglandin,E2alpha, Prostaglandin,Gel, Prepidil,alpha, PGE2,alpha, Prostaglandin E2
D017737 Macrophages, Peritoneal Mononuclear phagocytes derived from bone marrow precursors but resident in the peritoneum. Peritoneal Macrophages,Macrophage, Peritoneal,Peritoneal Macrophage

Related Publications

Tadayoshi Kaneko, and Hiroshige Chiba, and Norio Horie, and Takao Kato, and Masaki Kobayashi, and Ken Hashimoto, and Kaoru Kusama, and Hiroshi Sakagami
December 1981, Inflammation,
Tadayoshi Kaneko, and Hiroshige Chiba, and Norio Horie, and Takao Kato, and Masaki Kobayashi, and Ken Hashimoto, and Kaoru Kusama, and Hiroshi Sakagami
February 2004, International journal of cancer,
Tadayoshi Kaneko, and Hiroshige Chiba, and Norio Horie, and Takao Kato, and Masaki Kobayashi, and Ken Hashimoto, and Kaoru Kusama, and Hiroshi Sakagami
November 2009, Archives of pharmacal research,
Tadayoshi Kaneko, and Hiroshige Chiba, and Norio Horie, and Takao Kato, and Masaki Kobayashi, and Ken Hashimoto, and Kaoru Kusama, and Hiroshi Sakagami
September 2003, Current drug targets. Inflammation and allergy,
Tadayoshi Kaneko, and Hiroshige Chiba, and Norio Horie, and Takao Kato, and Masaki Kobayashi, and Ken Hashimoto, and Kaoru Kusama, and Hiroshi Sakagami
October 1980, Obstetrical & gynecological survey,
Tadayoshi Kaneko, and Hiroshige Chiba, and Norio Horie, and Takao Kato, and Masaki Kobayashi, and Ken Hashimoto, and Kaoru Kusama, and Hiroshi Sakagami
October 1983, Prostaglandins, leukotrienes, and medicine,
Tadayoshi Kaneko, and Hiroshige Chiba, and Norio Horie, and Takao Kato, and Masaki Kobayashi, and Ken Hashimoto, and Kaoru Kusama, and Hiroshi Sakagami
July 1991, British journal of obstetrics and gynaecology,
Tadayoshi Kaneko, and Hiroshige Chiba, and Norio Horie, and Takao Kato, and Masaki Kobayashi, and Ken Hashimoto, and Kaoru Kusama, and Hiroshi Sakagami
August 1987, Prostaglandins,
Tadayoshi Kaneko, and Hiroshige Chiba, and Norio Horie, and Takao Kato, and Masaki Kobayashi, and Ken Hashimoto, and Kaoru Kusama, and Hiroshi Sakagami
July 2016, Nitric oxide : biology and chemistry,
Tadayoshi Kaneko, and Hiroshige Chiba, and Norio Horie, and Takao Kato, and Masaki Kobayashi, and Ken Hashimoto, and Kaoru Kusama, and Hiroshi Sakagami
June 1992, Carcinogenesis,
Copied contents to your clipboard!